AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on Friday.
Missouri's highest court on Tuesday refused to consider Johnson & Johnson's appeal of a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in its baby powder and other talc products. Bryan Wood reports.
British drugmaker AstraZeneca is working with regulators to investigate a lower dosage of its vaccine that performed better than a full dosage, a spokesman for the company said on Thursday, after its chief executive was quoted as saying an additional global trial was likely. This report produced by Jillian Kitchener.
AstraZeneca and the University of Oxford are facing criticism over their COVID-19 vaccine trial results. According to Business Insider the criticism comes after AstraZeneca admitted to a mistake in the vaccine dosage. During the vaccine trial, some patients got two full doses of the vaccine. Others had a half-dose in their first shot, followed by a full dose. On Wednesday, an AstraZeneca executive described the "mistake" as "serendipity.
A manufacturing error is raising concerns about a promising COVID-19 vaccine being developed. The vaccine was developed by pharmaceutical company AstraZeneca and the University of Oxford. Less than a week after we learned about it, the developers have admitted to a manufacturing error. The error resulted from two different doses during the recently concluded phase III trial. AstraZeneca and the University of Oxford described the vaccine as being 70% effective.
Moderna's coronavirus vaccine candidate is 94.5% effective at protecting people against COVID-19. The candidate took under a year to develop and test, which is years faster than previous vaccines. The company designed its vaccine candidate in just two days, says Business Insider. In contrast, traditional vaccines can take years to design. Vaccines will hopefully be rolled out by Spring of 2021.
Elephant rides at Jaipur's Amer Fort resumed after months-long closure. The rides were prohibited due to COVID pandemic. Mahouts breathed a sigh of relief after state govt granted permission. Elephant safari is one of the key attractions at famous Amer Fort.
The S&P 500 and the Dow retreated Wednesday as a surprise rise in weekly jobless claims added to signs the recovery of the labor market was stalling amid a surge in COVID-19 infections. Fred Katayama reports.
Leaders of the world's 20 biggest economies on Sunday will pledge to pay for a fair distribution of COVID-19 vaccines, drugs and tests around the world so that poorer countries are not left out, and to extend debt relief to them, a draft G20 communique showed. Fred Katayama reports.
Wisconsin's governor on Friday extended a statewide mask mandate despite a legal challenge from conservatives, renewing an emergency health order requiring face coverings in public spaces to curb an alarming surge in COVID-19 infections. Fred Katayama reports.
LONDON — The University of Oxford and AstraZeneca's coronavirus vaccine was 90 percent effective in preventing COVID-19 In studies of more than 22,000 people in the UK and Brazil, AstraZeneca said in..